We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Adtran
ADTN
$798M
| $3K | ﹤0.01% |
+175
| New | +$3.8K |
|
2002
Abercrombie & Fitch
ANF
$4.17B
| $3K | ﹤0.01% |
253
+239
| +1,707% | +$2.84K |
|
2003
AngioDynamics
ANGO
$562M
| $3K | ﹤0.01% |
+204
| New | +$3.41K |
|
2004
Accuray
ARAY
$28.4M
| $3K | ﹤0.01% |
+765
| New | +$3.98K |
|
2005
Banc of California
BANC
$3.28B
| $3K | ﹤0.01% |
146
| – | – |
|
2006
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $3K | ﹤0.01% |
170
-5
| -3% | -$107 |
|
|
CLLS
2007
Cellectis
CLLS
$286M
| $3K | ﹤0.01% |
+150
| New | +$3.15K |
|
|
CSGS
2008
DELISTED
CSG Systems International
CSGS
| $3K | ﹤0.01% |
92
-6,526
| -99% | -$277K |
|
2009
Customers Bancorp
CUBI
$2.59B
| $3K | ﹤0.01% |
+105
| New | +$3.57K |
|
|
CUK
2010
DELISTED
Carnival PLC
CUK
| $3K | ﹤0.01% |
68
| – | – |
|
2011
Deckers Outdoor
DECK
$13.3B
| $3K | ﹤0.01% |
+360
| New | +$3.32K |
|
2012
Encompass Health
EHC
$11.2B
| $3K | ﹤0.01% |
+104
| New | +$3.42K |
|
2013
Essex Property Trust
ESS
$18.9B
| $3K | ﹤0.01% |
15
| – | – |
|
2014
Hain Celestial
HAIN
$47.8M
| $3K | ﹤0.01% |
106
-513
| -83% | -$19.3K |
|
2015
InterDigital
IDCC
$6.68B
| $3K | ﹤0.01% |
36
-7,393
| -100% | -$664K |
|
2016
Lindsay Corp
LNN
$1.16B
| $3K | ﹤0.01% |
+43
| New | +$3.37K |
|
2017
Logitech
LOGI
$15.2B
| $3K | ﹤0.01% |
+120
| New | +$3.45K |
|
2018
Pediatrix Medical
MD
$2.16B
| $3K | ﹤0.01% |
46
| – | – |
|
|
KG
2019
Kestrel Group
KG
$71.3M
| $3K | ﹤0.01% |
13
-1,620
| -99% | -$533K |
|
|
MRC
2020
DELISTED
MRC Global
MRC
| $3K | ﹤0.01% |
+191
| New | +$3.79K |
|
2021
Marvell Technology
MRVL
$174B
| $3K | ﹤0.01% |
203
+15
| +8% | +$231 |
|
2022
Strategy Inc
MSTR
$33.5B
| $3K | ﹤0.01% |
+200
| New | +$3.88K |
|
2023
Manitowoc
MTW
$516M
| $3K | ﹤0.01% |
162
+86
| +113% | +$2.12K |
|
2024
Mueller Water Products
MWA
$3.92B
| $3K | ﹤0.01% |
316
-45,619
| -99% | -$579K |
|
2025
Myers Industries
MYE
$1.18B
| $3K | ﹤0.01% |
+224
| New | +$3.18K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.